跳至主要内容
临床试验/JPRN-UMIN000026561
JPRN-UMIN000026561已完成2 期

A phase II study of carbon-ion radiotherapy for patients with hepatocellular carcinoma developing multiple lesions or complications - Carbon-ion radiotherapy for multiple lesions of hepatocellular carcinoma (iROCK-1604LI)

Kanagawa Cancer Center, Kanagawa Prefectural Hospital Organization0 个研究点目标入组 41 人开始时间: 2017年3月16日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
41

研究概览

简要总结

This study confirmed safety and efficacy comparable to those reported from prior facilities.

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Patients who are expected within one year of survival even after treatment of hepatocellular carcinoma 2) Past history of radiotherapy for target lesion 3) Patients with gastroesophageal varix which should be treated 4) Patients with 38 C or more of fever at registration of this trial or with infection which requires systemic treatment 5) Pregnant, possibly pregnant, within 28 days after delivery or breast-feeding female 6) Patients who are difficult to be participated in this trail due to psychological diseases, intractable heart or lung diseases at registration 7) Patients who are not suitable to be participated due to medical reason evaluated by primary physician

研究者

发起方
Kanagawa Cancer Center, Kanagawa Prefectural Hospital Organization

相似试验